Synairgen PLC SNG-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 4:08 PM BST
6.41UNCH (UNCH)
52 week range
4.00 - 11.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.16
  • 52 Week High11.00
  • 52 Week High Date11/28/23
  • 52 Week Low4.00
  • 52 Week Low Date03/22/24

Key Stats

  • Market Cap16.68M
  • Shares Out201.37M
  • 10 Day Average Volume170,827.22
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change7.28

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.16
  • 52 Week High11.00
  • 52 Week High Date11/28/23
  • 52 Week Low4.00
  • 52 Week Low Date03/22/24
  • Market Cap16.68M
  • Shares Out201.37M
  • 10 Day Average Volume170,827.22
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change7.28

RATIOS/PROFITABILITY

  • EPS (TTM)-4.96
  • P/E (TTM)-1.29
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Synairgen PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company; Synairgen Inc. and Synairgen Research (Ireland) Limited. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B...
Simon Shaw
Non-Executive Chairman of the Board
Richard Marsden
Chief Executive Officer, Executive Director
Joseph Colliver
Chief Financial Officer, Executive Director
Address
Southampton General Hosp, Tremona Road
Southampton
SO16 6YD
United Kingdom